Chemoinformaics analysis of 1,1-Dimethylcyclohexane
| Molecular Weight | 112.216 | nRot | 0 |
| Heavy Atom Molecular Weight | 96.088 | nRig | 22 |
| Exact Molecular Weight | 112.125 | nRing | 1 |
| Solubility: LogS | -4.152 | nHRing | 0 |
| Solubility: LogP | 2.996 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
| Atoms Count | 24 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 8 | No. of Aromatic Carbocycles | 0 |
| nHetero | 0 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 1 |
| No. of Hydrogen atom | 16 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 8 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 0 | No. of Arom Bond | 0 |
| nHA | 0 | APOL | 24.0287 |
| nHD | 0 | BPOL | 16.0513 |
| QED | 0.736 |
| Synth | 2.663 |
| Natural Product Likeliness | 1.568 |
| NR-PPAR-gamma | 0.912 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.998 |
| Pgp-sub | 0 |
| HIA | 0.006 |
| CACO-2 | -4.825 |
| MDCK | 0.0000233 |
| BBB | 0.004 |
| PPB | 0.911173 |
| VDSS | 0.767 |
| FU | 0.125355 |
| CYP1A2-inh | 0.903 |
| CYP1A2-sub | 0.785 |
| CYP2c19-inh | 0.807 |
| CYP2c19-sub | 0.079 |
| CYP2c9-inh | 0.819 |
| CYP2c9-sub | 0.827 |
| CYP2d6-inh | 0.69 |
| CYP2d6-sub | 0.759 |
| CYP3a4-inh | 0.752 |
| CYP3a4-sub | 0.148 |
| CL | 8.543 |
| T12 | 0.582 |
| hERG | 0.038 |
| Ames | 0.58 |
| ROA | 0.205 |
| SkinSen | 0.253 |
| Carcinogencity | 0.714 |
| EI | 0.854 |
| Respiratory | 0.19 |
| NR-Aromatase | 0.737 |
| Antiviral | No |
| Prediction | 0.954681 |